PCSK9 Inhibitor, EGF-A
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
PCSK9 Inhibitor, EGF-A is an inhibitor of PCSK9. It corresponds to residues 293-334 of the EGF-A domain of the low-density lipoprotein (LDL) receptor. This compound prevents PCSK9-induced intracellular degradation of LDL receptors and can be utilized in the research of hypercholesterolemia and premature atherosclerosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GM-48-30 1 mL
Colloidal Gold Conjugated Monoclonal Antibody to Chlamydia, 30nm
Sign In for Pricing
View Details 
BNC683177-500 1x 500 µL
TAG-72 / CA72.4 (Tumor-Associated Glycoprotein) (rB72.3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP20300PU-N 100 µg
Eph receptor B1 (EPHB1) (+EphB2) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details